HIV Infection, Immunosuppression, and Age at Diagnosis of Non-AIDS-Defining Cancers
Open accessThe DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
Background.: It is unclear whether immunosuppression leads to younger ages at cancer diagnosis among people living with human immunodeficiency virus (PLWH). A previous study found that most cancers are not diagnosed at a younger age in people with AIDS, with the exception of anal and lung cancers. This study extends prior work to include all PLWH and examines associations between AIDS, CD4 count, and age at cancer diagnosis. Methods.: We compared the median age at cancer diagnosis between PLWH in the North American AIDS Cohort Collaboration on Research and Design and the general population using data from the Surveillance, Epidemiology and End Results Program. We used statistical weights to adjust for population differences. We also compared median age at cancer diagnosis by AIDS status and CD4 count. Results.: After adjusting for population differences, younger ages at diagnosis (P < .05) were observed for PLWH compared with the general population for lung (difference in medians = 4 years), anal (difference = 4), oral cavity/pharynx (difference = 2), and kidney cancers (difference = 2) and myeloma (difference = 4). Among PLWH, having an AIDS-defining event was associated with a younger age at myeloma diagnosis (difference = 4; P = .01), and CD4 count <200 cells/µL (vs ≥500) was associated with a younger age at lung cancer diagnosis (difference = 4; P = .006). Conclusions.: Among PLWH, most cancers are not diagnosed at younger ages. However, this study strengthens evidence that lung cancer, anal cancer, and myeloma are diagnosed at modestly younger ages, and also shows younger ages at diagnosis of oral cavity/pharynx and kidney cancers, possibly reflecting accelerated cancer progression, etiologic heterogeneity, or risk factor exposure in PLWH.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“recent research72–74 indicates that one must disaggregate the between-person and within-person components of time-varying predictors (i.e., the mediators), and estimate both effects in the same model.”
From Evaluation of an integrated treatment to address smoking cessation and anxiety/depressive symptoms among people living with HIV: Study protocol for a randomized controlled trial (2021) · cites this paper as [73]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Castro, K. G., Ward, J. W., Slutsker, L., Buehler, J. W., Jaffe, H. W., Berkelman, R. L., & Curran, J. W. (1993) · Clinical Infectious Diseases · doi:10.1093/clinids/17.4.802 · Cited by 4,349
International Classification of Diseases for Oncology
National Cancer Institute (2020) · Definitions · doi:10.32388/1bjeus · Cited by 3,805
Screening for Lung Cancer: U.S. Preventive Services Task Force Recommendation Statement
Moyer, V. A., & on behalf of the U.S. Preventive Services Task Force* (2014) · Annals of Internal Medicine · doi:10.7326/m13-2771 · Cited by 2,632
Grulich, A. E., van Leeuwen, M. T., Falster, M. O., & Vajdic, C. M. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61050-2 · Cited by 2,323 · cited 1×
“People living with human immunodeficiency virus (PLWH) are at increased risk of several cancer types, including those considered to be AIDS-defining events (ie, Kaposi sarcoma, certain non-Hodgkin lymphomas, and invasive cervical cancer), as well other types of cancer, particularly anal, lung, and liver cancers, and H…”
BackgroundInternational Classification of Diseases for Oncology
Trott, P. A. (1977) · Journal of Clinical Pathology · doi:10.1136/jcp.30.8.782-c · Cited by 1,676
A review of human carcinogens–Part E: tobacco, areca nut, alcohol, coal smoke, and salted fish
Secretan, B., Straif, K., Baan, R., Grosse, Y., El Ghissassi, F., Bouvard, V., Benbrahim-Tallaa, L., Guha, N., Freeman, C., Galichet, L., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70326-2 · Cited by 1,114 · cited 2×
“As lung and anal cancers are primarily caused by cigarette smoking [26] and high-risk HPV infections [27], respectively, it is possible that earlier or more intense exposure to cigarette smoking and anal HPV could result in younger ages at cancer diagnosis.”
Background(1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03500040022009 · Cited by 958
Cancer Burden in the HIV-Infected Population in the United States
Shiels, M. S., Pfeiffer, R. M., Gail, M. H., Hall, H. I., Li, J., Chaturvedi, A. K., Bhatia, K., Uldrick, T. S., Yarchoan, R., Goedert, J. J., et al. (2011) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djr076 · Cited by 778 · cited 2×
“Cancer prevention and early detection is particularly important as the number of older PLWH continues to grow [4].”
BackgroundSelf-citationCarcinogenicity of human papillomaviruses
Cogliano, V., Baan, R., Straif, K., Grosse, Y., Secretan, B., & Ghissassi, F. E. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70086-3 · Cited by 688
Cumulative Incidence of Cancer Among Persons With HIV in North America: A Cohort Study
Silverberg, M. J., Lau, B., Achenbach, C. J., Jing, Y., Althoff, K. N., D'Souza, G., Engels, E. A., Hessol, N. A., Brooks, J. T., Burchell, A. N., et al. (2015) · Annals of Internal Medicine · doi:10.7326/m14-2768 · Cited by 328 · cited 1×
“Individual cohorts validated cancer diagnoses through medical records, pathology reports, or linkage with cancer registries [16].”
BackgroundSelf-citation
Research works printed but not linked: 3
- 11. Centers for Disease Control and Prevention. HIV surveillance report, 2014; vol. 26 Available at: http://www.cdc.gov/hiv/pdf/library/reports/surveillance/cdc-hiv-surveillance-report-us.pdf Accessed 17 February 2016. [Google Scholar]
- 12. Howden LMM, Meyer JA. Age and sex composition: 2010 Census briefs. US Census Bureau: Washington, DC, 2011. [Google Scholar]
- 20. Statistics Canada. Population by broad age groups and sex, 2011 counts for both sexes, for Canada, provinces and territories. Available at: http://www12.statcan.gc.ca/census-recensement/2011/dp-pd/hlt-fst/as-sa/Pages/highlight.cfm?TabID=1&Lang=E&Asc=1&PRCode=01&OrderBy=999&Sex=1&View=1&tableID=21&queryID=1 Accessed 10 May 2016.
Cited by
Rivera, M. P., Katki, H. A., Tanner, N. T., Triplette, M., Sakoda, L. C., Wiener, R. S., Cardarelli, R., Carter-Harris, L., Crothers, K., Fathi, J. T., et al. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202008-3053st · Cited by 243
Anal Cancer Risk Among People With HIV Infection in the United States
Colón-López, V., Shiels, M. S., Machin, M., Ortiz, A. P., Strickler, H., Castle, P. E., Pfeiffer, R. M., & Engels, E. A. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.74.9291 · Cited by 224
“Among these individuals, a low CD4 count is associatedwith an increased risk of anal cancer,(12,13) and immunosuppression seems most important at early stages in the development of anal cancer.(14) Although anal cancer incidence did not clearly decline during the first decade of the HAARTera, a lag might have been pos…”
BackgroundSelf-citationHorberg, M. A., Thompson, M., Agwu, A. L., Colasanti, J. A., Haddad, M. S., Jain, M. K., McComsey, G. A., Radix, A., Rakhmanina, N. Y., Short, W. R., et al. (2024) · Clinical Infectious Diseases · doi:10.1093/cid/ciae479 · Cited by 185
Achieving the fourth 90: healthy aging for people living with HIV
Harris, T. G., Rabkin, M., & El‐Sadr, W. (2018) · AIDS · doi:10.1097/qad.0000000000001870 · Cited by 145
Reddy, K. P., Kong, C. Y., Hyle, E. P., Baggett, T. P., Huang, M., Parker, R. A., Paltiel, A. D., Losina, E., Weinstein, M. C., Freedberg, K. A., et al. (2017) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2017.4349 · Cited by 136
Epidemiology of haematological malignancies in people living with HIV
Kimani, S., Painschab, M., Horner, M., Muchengeti, M. M., Fedoriw, Y. D., Shiels, M. S., & Gopal, S. (2020) · The Lancet HIV · doi:10.1016/s2352-3018(20)30118-1 · Cited by 118
Self-citationCD4/CD8 Ratio and Cancer Risk Among Adults With HIV
Castilho, J. L., Bian, A., Jenkins, C. A., Shepherd, B. E., Sigel, K. M., Gill, M. J., Kitahata, M. M., Silverberg, M. J., Mayor, Á. M., Coburn, S. B., et al. (2022) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djac053 · Cited by 95
Self-citationAge at diagnosis for lung, colon, breast and prostate cancers: An international comparative study
Zahed, H., Feng, X., Sheikh, M., Bray, F., Ferlay, J., Ginsburg, O., Shiels, M. S., & Robbins, H. A. (2023) · International Journal of Cancer · doi:10.1002/ijc.34671 · Cited by 90
Self-citationNanditha, N. G. A., Paiero, A., Tafessu, H. M., St‐Jean, M., McLinden, T., Justice, A. C., Kopec, J. A., Montaner, J. S. G., Hogg, R. S., & Lima, V. D. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-041734 · Cited by 87
Self-citationKaplan‐Lewis, E., Aberg, J. A., & Lee, M.-K. (2017) · Seminars in Diagnostic Pathology · doi:10.1053/j.semdp.2017.04.002 · Cited by 82
“This data suggests that history of immunosuppression, even after immune reconstitution, is important in shaping cancer risk (193).”
BackgroundTheron, A. J., Anderson, R., Rossouw, T. M., & Steel, H. C. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01461 · Cited by 88
Non-AIDS comorbidity burden differs by sex, race, and insurance type in aging adults in HIV care
Palella, F. J., Hart, R. L. D., Armon, C., Tedaldi, E., Yangco, B. G., Novák, R., Battalora, L. A., Ward, D. J., Li, J., & Buchacz, K. A. (2019) · AIDS · doi:10.1097/qad.0000000000002349 · Cited by 75
“possibly by up to a decade or more [4,5].”
BackgroundNeurological Complications of HIV Infection
Farhadian, S., Patel, P. B., & Spudich, S. (2017) · Current Infectious Disease Reports · doi:10.1007/s11908-017-0606-5 · Cited by 77
Moulignier, A., Savatovsky, J., Assoumou, L., Lescure, F.-X., Lamirel, C., Godin, O., Valin, N., Tubiana, R., Canestri, A., Roux, P., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix1075 · Cited by 62
HIV-Associated Cancers and Related Diseases
Chamseddine, A. N., Loulergue, P., & Mir, O. (2018) · New England Journal of Medicine · doi:10.1056/nejmc1804812 · Cited by 60
Edwards, J. K., Cole, S. R., Breger, T. L., Rudolph, J. E., Filiatreau, L. M., Buchacz, K. A., Humes, E., Rebeiro, P. F., DʼSouza, G., Gill, M. J., et al. (2021) · Annals of Internal Medicine · doi:10.7326/m21-0065 · Cited by 64
Self-citationHuman Immunodeficiency Virus and Aging in the Era of Effective Antiretroviral Therapy
Epps, P. V., & Kalayjian, R. C. (2017) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2017.07.007 · Cited by 61
Belkina, A. C., Starchenko, A., Drake, K., Proctor, E. A., Pihl, R. M. F., Olson, A., Lauffenburger, D. A., Lin, N., & Snyder-Cappione, J. E. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02783 · Cited by 40
Implications of Tumor–Immune Coevolution on Cancer Evasion and Optimized Immunotherapy
George, J. T., & Levine, H. (2021) · Trends in cancer · doi:10.1016/j.trecan.2020.12.005 · Cited by 44
Taiwo, B., Romdhani, H., Lafeuille, M., Bhojwani, R., Milbers, K., & Donga, P. Z. (2022) · Journal of Drug Assessment · doi:10.1080/21556660.2022.2149963 · Cited by 39
Are Non-HIV Malignancies Increased in the HIV-Infected Population?
Thrift, A. P., & Chiao, E. Y. (2018) · Current Infectious Disease Reports · doi:10.1007/s11908-018-0626-9 · Cited by 38
VIH et cancer : mise au point en 2020
Abbar, B., Veyri, M., Solas, C., Poizot‐Martin, I., & Spano, J. (2020) · Bulletin du Cancer · doi:10.1016/j.bulcan.2020.01.001 · Cited by 34
Prevalence of HPV in anal cancer: exploring the role of infection and inflammation
Ebrahimi, F., Rasizadeh, R., Jafari, S., & Baghi, H. B. (2024) · Infectious Agents and Cancer · doi:10.1186/s13027-024-00624-0 · Cited by 36
The clinical features and prognosis of 100 AIDS-related lymphoma cases
Wu, D., Chen, C., Zhang, M., Li, Z., Wang, S., Shi, J., Zhang, Y., Yao, D., & Hu, S. (2019) · Scientific Reports · doi:10.1038/s41598-019-41869-9 · Cited by 32
Managing HIV infection in patients older than 50 years
McMillan, J. M., Krentz, H. B., Gill, M. J., & Hogan, D. B. (2018) · Canadian Medical Association Journal · doi:10.1503/cmaj.171409 · Cited by 36
Trickey, A., May, M., Gill, M. J., Grabar, S., Vehreschild, J. J., Wit, F. W. N. M., Bonnet, F., Cavassini, M. L., Abgrall, S., Berenguer, J., et al. (2020) · International Journal of Cancer · doi:10.1002/ijc.32895 · Cited by 31
“22,23 We studied cause-speci fi c mortality after diagnosis of speci fi c cancers to answer the question: what do PLHIV diagnose with cancer die of?”
BackgroundSelf-citationEngels, E. A., Shiels, M. S., Barnabas, R. V., Bohlius, J., Brennan, P., Castilho, J. L., Chanock, S. J., Clarke, M. A., Coghill, A. E., Combes, J., et al. (2023) · International Journal of Cancer · doi:10.1002/ijc.34727 · Cited by 32
“Although the average age at diagnosis for many cancer types appears to be younger among PLWH than among people without HIV, much of this is an artifact of the younger age distributions of the population of PLWH. 35,36 Moreover, the incidence of common age-related cancers (eg, colorectal, prostate and breast) is not el…”
BackgroundInfluentialSelf-citationCattelan, A. M., Mazzitelli, M., Presa, N., Cozzolino, C., Sasset, L., Leoni, D., Bragato, B., Scaglione, V., Baldo, V., & Parisi, S. G. (2023) · Cancers · doi:10.3390/cancers16010070 · Cited by 25
Risk factors and impact of patterns of co-occurring comorbidities in people living with HIV
Francesco, D. D., Underwood, J., Bagkeris, E., Anderson, J., Williams, I. G., Vera, J. H., Post, F. A., Boffito, M., Johnson, M. A., Mallon, P. W. G., et al. (2019) · AIDS · doi:10.1097/qad.0000000000002293 · Cited by 25
“prolonged immune activation and inflammation and/or severe immunosuppression may have contributed to an increased burden of non-AIDS-defining cancers, as also suggested by a previous study [29].”
ResultSuárez‐García, I., Gutiérrez, F., Pérez-Molina, J. A., Moreno, S., Aldámiz‐Echevarría, T., Ortega, E. V., Curran, A., González, S. G., Asensi, V., Prous, C. A., et al. (2023) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-023-05500-9 · Cited by 19
Mathur, P., Kottilil, S., Pallikkuth, S., Frasca, D., & Ghosh, A. (2022) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000003080 · Cited by 20
Contribution of behavioral health factors to non-AIDS-related comorbidities: an updated review
Chichetto, N. E., Polanka, B. M., So-Armah, K. A., Sung, M., Stewart, J. C., Koethe, J. R., Edelman, E. J., Tindle, H. A., & Freiberg, M. S. (2020) · Current HIV/AIDS Reports · doi:10.1007/s11904-020-00498-y · Cited by 17
Optimal Lung Cancer Screening Criteria Among Persons Living With HIV
Sellers, S. A., Edmonds, A., Ramirez, C., Cribbs, S. K., Ofotokun, I., Huang, L., Morris, A., McCormack, M. C., Kunisaki, K. M., DʼSouza, G., et al. (2022) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000002930 · Cited by 17
Self-citationMakinson, A., Park, L. S., Stone, K., Tate, J., Rodriguez‐Barradas, M. C., Brown, S. T., Wadia, R. J., Crothers, K. A., Bedimo, R., Goetz, M. B., et al. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab389 · Cited by 17
Klugman, M. F., Fazzari, M. J., Xue, X., Ginsberg, M. S., Rohan, T. E., Halmos, B., Hanna, D. B., Shuter, J., & Hosgood, H. D. (2021) · AIDS Care · doi:10.1080/09540121.2021.1934380 · Cited by 14
Head and neck squamous cell carcinoma in people living with HIV in France
Picard, A., Arowas, L., Piroth, L., Heard, I., & Ferry, T. (2018) · Médecine et Maladies Infectieuses · doi:10.1016/j.medmal.2018.05.002 · Cited by 14
Nicolau, I. A., Moineddin, R., Brooks, J. D., Antoniou, T., Gillis, J. L., Kendall, C., Cooper, C., Cotterchio, M., Salters, K. A., Smieja, M., et al. (2024) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000003452 · Cited by 13
“60,61 This also aligns with the immunosurveillance hypothesis that lowered immune function allows infections with oncogenic viruses or bacteria to persist into cancer.”
Dutta, A., Uno, H., Holman, A., Lorenz, D. R., & Gabuzda, D. H. (2017) · Cancer Causes & Control · doi:10.1007/s10552-017-0896-9 · Cited by 14
“…America found that while age at prostate cancer diagnosis was younger among HIV-infected subjects, the difference was not statistically significant (21); findings were inconclusive with respect to young-onset prostate cancer in groups by HIV status because age was examined in 10-year bins rather…”
Oka, S., Ikeda, K., Takano, M., Ogane, M., Tanuma, J., Tsukada, K., & Gatanaga, H. (2020) · Global Health & Medicine · doi:10.35772/ghm.2019.01030 · Cited by 13
Camandaroba, M. P. G., Iseas, S., Oliveira, C. P. D. F., Taboada, R. G., Xerfan, M. P., Mauro, C., Silva, V. S. E., Barros, M. J., de Jesus, V. H. F., Felismino, T. C., et al. (2020) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2020.03.006 · Cited by 13
HIV Modifies the Effect of Tobacco Smoking on Oral Human Papillomavirus Infection
Alli, B. Y., Burk, R. D., Fatahzadeh, M., Kazimiroff, J., Grossberg, R. M., Smith, R. V., Ow, T. J., Wiltz, M. J., Polanco, J., Rousseau, M., et al. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa135 · Cited by 13
MacDuffie, E., Sakamuri, S., Luckett, R. L., Wang, Q., Bvochara-Nsingo, M., Monare, B., Bazzett‐Matabele, L., Moloi, T., Ralefala, T. B., Ramogola‐Masire, D., et al. (2021) · International Journal of Gynecological Cancer · doi:10.1136/ijgc-2021-002728 · Cited by 12
Self-citationNicolau, I. A., Antoniou, T., Brooks, J. D., Moineddin, R., Cooper, C., Cotterchio, M., Gillis, J. L., Kendall, C., Kroch, A. E., Lindsay, J. D., et al. (2022) · CMAJ Open · doi:10.9778/cmajo.20220012 · Cited by 12
“This includes discussing cancer risk with patients, encouraging risk reduction such as smoking cessation, and encouraging uptake of primary and secondary interventions for cancer prevention, such as HPV vaccination, hepatitis C treatment and screening for HPV-related cancers and colorectal cancer.”
Barnell, G. M., Merchant, M. A., Lam, J. O., & Silverberg, M. J. (2019) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000002040 · Cited by 12
Self-citationTanaka, T., Oshima, K., Kawano, K., Tashiro, M., Kakiuchi, S., Tanaka, A., Fujita, A., Ashizawa, N., Tsukamoto, M., Yasuoka, A., et al. (2024) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000003389 · Cited by 11
Anastasia, A., Mazzucco, W., Pipitò, L., Fruscione, S., Gaudiano, R., Trizzino, M., Zarcone, M., & Cascio, A. (2025) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2025.102661 · Cited by 10
Piselli, P., Tavelli, A., Cimaglia, C., Muccini, C., Bandera, A., Marchetti, G. C., Torti, C., Mazzotta, V., Pipitò, L., Caioli, A., et al. (2025) · International Journal of Cancer · doi:10.1002/ijc.35493 · Cited by 10
“25 Another study, using the French Hospital Database on HIV, observed younger ages at diagnosis for lung, but not anal cancer.”
Chemotherapy-Induced Hepatotoxicity in HIV Patients
Bressan, S., Pierantoni, A., Sharifi, S., Facchini, S., Quagliariello, V., Berretta, M., & Montopoli, M. (2021) · Cells · doi:10.3390/cells10112871 · Cited by 10
“Statistically significant is also the difference between the type of cancer, where the youngest population is mostly affected by cancer like lung and anal cancer, while at older ages the diagnosis of Hodgkin lymphoma has been more reported [24,25].”
BackgroundMakinson, A., Tron, L., Grabar, S., Milleron, B. J., Reynes, J., Moing, V. L., Morquin, D., Lert, F., Costagliola, D. G., & Guiguet, M. (2019) · HIV Medicine · doi:10.1111/hiv.12811 · Cited by 9
Zhang, H., Kim, S., Chen, Z., Nannapaneni, S., Chen, A. Y., Moore, C. E., Sica, G., Mošunjac, M., Nguyen, M. L., DʼSouza, G., et al. (2017) · Head & Neck · doi:10.1002/hed.24911 · Cited by 9
Self-citationPathophysiology of Anal Cancer
Ložar, T., & Carchman, E. H. (2024) · Surgical Oncology Clinics of North America · doi:10.1016/j.soc.2024.07.003 · Cited by 8
Agrawal, R., Tofighbakhsh, A., Davidson, J., & Gabriele, J. (2025) · Current Surgery Reports · doi:10.1007/s40137-024-00442-8 · Cited by 7
Secular Trends in Breast Cancer Risk Among Women With HIV Initiating ART in North America
Coburn, S. B., Shiels, M. S., Silverberg, M. J., Horberg, M. A., Gill, M. J., Brown, T. T., Visvanathan, K., Connor, A. E., Napravnik, S., Marcus, J. L., et al. (2021) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000002627 · Cited by 7
Self-citationHIV and Age Do Not Synergistically Affect Age-Related T-Cell Markers
Farhadian, S., Jalbert, E., Deng, Y., Goetz, M. B., Park, L. S., Justice, A. C., Dubrow, R., & Emu, B. (2017) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001595 · Cited by 7
Self-citationWang, J., Liang, R., Hao, C., Liu, X., Zhang, N., Duan, X., Dong, H., Dong, B., Gu, H., Gao, G., et al. (2018) · Journal of Investigative Medicine · doi:10.1136/jim-2017-000636 · Cited by 7
Pita-Martínez, C., Jiménez‐Sousa, M. Á., Martínez‐Picado, J., Rodríguez, C. E. G., Fariñas, C., Galindo, P., Roca-Oporto, C., Santos, J., Muñoz-García, P., Rava, M., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1707510 · Cited by 6
Marbaniang, I., Joshi, S., Sangle, S. A., Khaire, S., Thakur, R., Chavan, A., Gupte, N., Kulkarni, V., Deshpande, P., Nimkar, S., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0270876 · Cited by 6
“People living with HIV (PLHIV) have a higher risk of oral cancer [2, 3], and in India this risk is estimated to be as high as 27 times that of the general population [4].”
BackgroundNon-AIDS-defining malignancies in Japanese hemophiliacs with HIV-1 infection
Oka, S., Ogata, M., Takano, M., Minamimoto, R., Hotta, M., Tajima, T., Nagata, N., Tsukada, K., Teruya, K., Kikuchi, Y., et al. (2019) · Global Health & Medicine · doi:10.35772/ghm.2019.01015 · Cited by 6
“Moreover, the risk of non-AIDS-defining malignancies (NADM) has been increasing (8-10), and NADM have become one of the major causes of death in HIVinfected patients (11).”
BackgroundMonapathi, M. E., Bezuidenhout, C. C., & Rhode, O. H. J. (2020) · Water SA · doi:10.17159/wsa/2020.v46.i4.9072 · Cited by 10
“133 182–207. https://doi.org/10.1016/j.watres.2017.12.029 UNAIDS (Joint United Nations Programme on HIV and AIDS) (2018) UNAIDS Programme Coordinating Board sees South Africa’s AIDS response first-hand. https://www.unaids.org/en/resources/pr esscentre/featurestories/2018/november/pcb-field-visit-south-africa (Accessed…”
BackgroundInfluentialLung cancer screening in people living with HIV: modeling to bridge the evidence
Robbins, H. A. (2018) · AIDS · doi:10.1097/qad.0000000000001819 · Cited by 6
Association of CD4+ cell count and HIV viral load with risk of non-AIDS-defining cancers
Ma, Y., Zhang, J., Yang, X., Chen, S., Weissman, S., Olatosi, B., Alberg, A. J., & Li, X. (2023) · AIDS · doi:10.1097/qad.0000000000003637 · Cited by 5
“Certain cancers offer potential for early detection through targeted screening or early diagnosis methods, while others do not [37,38].”
Tedaldi, E., Armon, C., Li, J., Mahnken, J. D., Simoncini, G. M., Palella, F. J., Carlson, K., Buchacz, K. A., for the HIV Outpatient Study (HOPS) Investigators, Durham, M. D., et al. (2022) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2021.0178 · Cited by 5
“31 Although first-line antiretroviral therapy (ART) recommendations for PWH have evolved in the last decade and most recently consolidated toward integrase strand transfer inhibitor (INSTI)-based regimens, there are limited reports on the burden of and the development of multiple key co-morbidities…”
Pillay, S. M., Moolla, Z., Moodley, Y., & Madiba, T. E. (2022) · African Health Sciences · doi:10.4314/ahs.v22i2.4 · Cited by 5
Bandera, A., Colella, E., Clerici, M., Rizzardini, G., & Gori, A. (2018) · AIDS · doi:10.1097/qad.0000000000002015 · Cited by 5
Age at Diagnosis of Heart Failure in United States Veterans With and Without HIV Infection
Erqou, S. A., Jiang, L., Choudhary, G., Lally, M., Freiberg, M. S., Lin, N., Shireman, T. I., Rudolph, J. L., & Wu, W. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.120.018983 · Cited by 5
Incidence of lung and human papilloma virus-associated malignancies in HIV-infected patients
Chaussade, H., Marec, F. L., Coureau, G., Leleux, O., Neau, D., Lazaro, E., Amadéo, B., Duffau, P., Ferrand, H., Courtault, C., et al. (2021) · AIDS · doi:10.1097/qad.0000000000003152 · Cited by 4
Garey, L., Wirtz, M. R., Labbe, A. K., Zvolensky, M. J., Smits, J. A. J., Giordano, T. P., Rosenfield, D., Robbins, G. K., Levy, D. E., McKetchnie, S. M., et al. (2021) · Contemporary Clinical Trials · doi:10.1016/j.cct.2021.106420 · Cited by 3
Nicolau, I. A., Moineddin, R., Antoniou, T., Brooks, J. D., Gillis, J. L., Kendall, C., Cooper, C., Cotterchio, M., Salters, K. A., Smieja, M., et al. (2023) · CMAJ Open · doi:10.9778/cmajo.20220230 · Cited by 3
Epidemiology and Pathogenesis of Anal Cancer
Roveda, J., & Smith, C. A. (2019) · Springer eBooks · doi:10.1007/978-3-030-20253-8_2 · Cited by 3
Kaufman, A. R., Ciccolo, J. T., Berzon, R. A., & Edelman, E. J. (2021) · Contemporary Clinical Trials · doi:10.1016/j.cct.2021.106518 · Cited by 2
Le cancer bronchopulmonaire chez les patients infectés par le VIH
Domblides, C., Canellas, A., Wislez, M., Fallet, V., Antoine, M., Créquit, P., Cadranel, J. L., & Lavolé, A. (2017) · Bulletin du Cancer · doi:10.1016/j.bulcan.2017.11.002 · Cited by 2
Review: The Impact of HIV Infection on Cancer Treatment with Immunotherapy
Granwehr, B. P. (2019) · Journal of Immunotherapy and Precision Oncology · doi:10.4103/jipo.jipo_14_19 · Cited by 2
Cioaia, S., Tornero, C., Sánchez, E. T., & Alos, M. (2019) · Journal of the International Association of Providers of AIDS Care (JIAPAC) · doi:10.1177/2325958219839077 · Cited by 1
“Human immunodefi ciency virus-infected individuals are at an increased risk of developing lung cancer, which moreover tends to manifest at an earlier age and in more advanced stages of the disease [2-5].”
BackgroundMethodRuppert, A.-M., Lavolé, A., Makinson, A., Maître, B. L., & Cadranel, J. L. (2020) · Revue des Maladies Respiratoires · doi:10.1016/j.rmr.2019.08.008 · Cited by 1
“En effet, l’âge au diagnostic de CB chez les PVVIH par rapport à la population générale est de 4 ans plus jeune environ [37,38] .”
BackgroundCancers among HIV Infected Patients: A Reason for Routine Screening
Isichei, M., Ale, A. F., Shitta, A. H., Misauno, M. A., & Isichei, C. O. (2017) · IOSR Journal of Dental and Medical Sciences · doi:10.9790/0853-1603050105
Anaya‐Saavedra, G., Ramírez‐Amador, V., Itzel, C., & Saeb‐Lima, M. (2019) · International Journal of STD & AIDS · doi:10.1177/0956462419838102
Carlos, T. (2017) · Journal of HIV for Clinical and Scientific Research · doi:10.17352/2455-3786.000121
Clark, E. H., & Chiao, E. Y. (2021) · Oxford University Press eBooks · doi:10.1093/med/9780197576595.003.0036
Clark, E. H., & Chiao, E. Y. (2023) · Oxford University Press eBooks · doi:10.1093/med/9780197679098.003.0029
Makinson, A., Grabar, S., Spano, J., Brégigeon, S., Heard, I., & Etienney, I. (2024) · Médecine et Maladies Infectieuses Formation · doi:10.1016/j.mmifmc.2024.01.004
The clinical prognostic risk stratification system for HIV infected hepatocellular carcinoma
Chen, Y., Zhao, H., Wang, Y., Liu, B., Chen, Z., Tao, Y., Yang, H., Yang, H., Liu, R., Feng, L., et al. (2024) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2024.102479
Oravec, T., Ready, E., Hull, M., & Wright, A. J. (2024) · Journal of the Association of Medical Microbiology and Infectious Disease Canada · doi:10.3138/jammi-2024-0013
Duff, A. J., Otieno, C. O., Chen, L., Mannion, K., Topf, M. C., Michels, B. E., Butt, J., Woodward, B. O., Lima, M. C., Erdem, H., et al. (2025) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-24-0420
Clark, E. H., & Chiao, E. Y. (2025) · Oxford University Press eBooks · doi:10.1093/med/9780197812631.003.0025
Duff, A. J., Junkins, A., Chen, L., Mannion, K., Topf, M. C., Waterboer, T., Michels, B. E., Butt, J., Woodward, B. O., Lima, M. C., et al. (2025) · Cancer · doi:10.1002/cncr.70167
Faherty, H., Shahid, J. N., Osba, Y. A., Jamshaid, M., Mital, D., & Ahmed, M. H. (2025) · Tropical Medicine and Infectious Disease · doi:10.3390/tropicalmed10110318
Le, N. T., Ta, N., Vu, T. T., Tran, K., Bui, T. C., Liu, H., & Ha, T. (2025) · HIV Medicine · doi:10.1111/hiv.70161
“Our findings are consistent with observations from other settings, where people with HIV exhibited higher cancer mortality risk at younger ages [29].”
Murphy, N. R., Snidarich, M., Budak, J. Z., Brown, M. C., Weiner, B. J., Giustini, N., Caverly, T. J., Ross, K., DeCell, K., Crothers, K. A., et al. (2025) · Health Promotion Practice · doi:10.1177/15248399251388644
“PWH develop lung cancer at a younger age, may be diagnosed at a more advanced stage, and appear to have worse survival (Hleyhel et al., 2015; Shiels et al., 2015, 2017, 2010).”
Islam, J. Y., Lappen, H., Commaroto, S. A., Edwards, D., & Kapadia, F. (2026) · Current Epidemiology Reports · doi:10.1007/s40471-025-00378-2
“HIV-related immuno-suppression may obscure early cancer symptoms [66–68] and PWH are often diagnosed with cancer at younger ages compared to the general population [ 69 ], underscoring the urgency of timely cancer screening initiation.”
Pita-Martínez, C., Muñoz-García, P., Martínez, I., Rava, M., Bautista, A., Pérez‐Somarriba, J., Campins, A. A., Mena, M. N., Vera, F., Montero‐Alonso, M., et al. (2026) · Journal of Medical Virology · doi:10.1002/jmv.70884
“However, this longevity is accompanied by a shift in morbidity, with non‐ AIDS‐defining cancers (NADCs) emerging as a primary health concern and a key challenge in modern HIV clinical practice [2].”
Zhou, Y., Lau, B. M., Rudolph, J. E., Xu, X., Calkins, K. L., Palatino, M. C., Yenokyan, K., Wentz, E., & Joshu, C. E. (2026) · BMC Cancer · doi:10.1186/s12885-026-16487-0
Lung cancer screening among people with HIV, 2018-2023
Sellers, S. A., Browne, L., Henderson, H., Moy, A., Agil, D., Durr, A. L., Farel, C. E., Eron, J. J., & Napravnik, S. (2026) · International Journal of STD & AIDS · doi:10.1177/09564624261469254
Self-citationCuming, T., Rozemeijer, K., Farrow, E., Cappello, C., Wait, B., Junejo, M. H., Bowring, J., Rosenthal, A. N., Richel, O., Nathan, M., et al. (2026) · Colorectal Disease · doi:10.1111/codi.70596
Masiá, M., Gutiérrez, A., García-Sánchez, L., Ledesma, C., Fernández‐González, M., Belló-Pérez, M., Mascarell, P., Botella, Á., García‐Abellán, J., Padilla, S., et al. (2026) · Clinical Infectious Diseases · doi:10.1093/cid/ciag620
Metadata
- Authors
- Shiels, M. S., Althoff, K. N., Pfeiffer, R. M., Achenbach, C. J., Abraham, A. G., Castilho, J., Cescon, A., D’Souza, G., Dubrow, R., Eron, J. J., Gebo, K., John Gill, M., Goedert, J. J., Grover, S., Hessol, N. A., Justice, A., Kitahata, M., Mayor, A., Moore, R. D., Napravnik, S., Novak, R. M., Thorne, J. E., Silverberg, M. J., Engels, E. A., & for the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of the International Epidemiologic Databases to Evaluate AIDS (IeDEA)
- Affiliations
- Division of Cancer Epidemiology and Genetics (US)
- Johns Hopkins University (US)
- Northwestern University (US)
- Vanderbilt University Medical Center (US)
- NOSM University (CA)
- Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health 2 , Baltimore, Maryland
- Yale University (US)
- University of North Carolina at Chapel Hill (US)
- Department of Medicine, University of Calgary 10 , Alberta ,
- University of Pennsylvania (US)
- University of California, San Francisco (US)
- University of Washington (US)
- School of Medicine, Universidad Central del Caribe 15 , Bayamon, Puerto Rico
- Division of Infectious Diseases, University of Illinois College of Medicine 16 , Chicago
- Kaiser Permanente (US)
- ORCID
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-01-07
- Volume
- 64
- Issue
- 4
- Pages
- 468-475
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- PMC
- PMC5850313
- OpenAlex
- W2560043256
- Cited by
- 95
- References
- 33
- Citations by year
- 2026: 6 · 2025: 9 · 2024: 8 · 2023: 7 · 2022: 6 · 2021: 15 · 2020: 10 · 2019: 10 · 2018: 10 · 2017: 14
- FWCI
- 6.11
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- public-domain
- Locations
- Clinical Infectious Diseases (publishedVersion, public-domain)
- PubMed Central (publishedVersion, public-domain)
- PubMed (publishedVersion)
- Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- UNC Libraries
- Funders
- Kaiser Permanente (UL1RR024131)
- Vanderbilt University
- University of Washington
- Johns Hopkins University (P30 AI 094189, P30CA006973)
- Case Western Reserve University
- Government of Alberta
- National Institutes of Health (CBR-86906, 90051652, 90047713), N02CP055504, CDC-200–2015–63931, CBR-94036, UL1TR000083, P30-AI- 027767, UL1TR000004, UL1TR000454, CDC-200–2006–18797, HCP-97105, KL2TR000421, TGF-96118, U01-AI068634, U01-AI069432, U01-AA013566)
- Centers for Disease Control and Prevention (P30-AI094189, 200-2006-18797, CDC200-2006-18797, HCP-97105, CBR-94036, TGF-96118, CBR-86906, 200-2015-63931, CDC-200-2015-63931, P30AI027767, 90047713, 90051652)
- Health Resources and Services Administration (90051652, HCP-97105, CBR-94036, TGF-96118, CBR-86906, 90047713)
- Agency for Healthcare Research and Quality (TGF-96118, 90051652, HCP-97105, CBR-94036, CBR-86906, 90047713)
- University of North Carolina at Chapel Hill
- Canadian Institutes of Health Research (90051652, HCP-97105,, 90047713, 96118_1, 86906_1, 94036_1)
- National Institute on Alcohol Abuse and Alcoholism (R01AA016893, U01AA020790, U24AA020794)
- National Institute on Aging (R01AG053100)
- National Institute of Mental Health (P30MH062246)
- National Institute on Drug Abuse (U01DA036935, R01DA012568, R01DA004334, R01DA011602, F31DA037788, K24DA000432)
- National Eye Institute (U10EY008067, U10EY008052, U10EY008057, K23EY013707)
- National Cancer Institute (CBR-86906, HCP-97105, CBR-94036, 90051652, R01CA165937, ZIACP010214, TGF-96118, Z01CP010214, 90047713, Z01CP010176, P30CA006973)
- National Institute of Allergy and Infectious Diseases (UM1AI035043, U01AI069434, U01AI103408, K01AI093197, U01AI034989, U01AI031834, U01AI103397, U01AI068636, U01AI038855, U01AI035040, P30AI054999, U01AI042590, U01AI037984, U01AI034993, U01AI035041, U01AI038858, U01AI034994, K24AI065298, K23AI120875, U01AI037613, U01AI035039, U01AI103390, U01AI035004, U01AI035042, U01AI103401, P30AI027757, P30AI036219, P30AI094189, R24AI067039, U01AI069918, P30AI050410, P30AI027763)
- National Center for Research Resources (UL1RR024131, M01RR000052)
- National Institute on Minority Health and Health Disparities (G12MD007583, U54MD007587)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (U01HD032632)
- Topics
- Health Sciences › Medicine › Oncology › Viral-associated cancers and disorders
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
- Health Sciences › Medicine › Infectious Diseases › HIV-related health complications and treatments
- Keywords
- HIV infection, non-AIDS-defining cancers, age at cancer diagnosis, immunosuppression, CD4 count, AIDS-defining events, lung cancer, anal cancer, multiple myeloma, kidney cancer, tumor progression, AIDS
- MeSH terms
- Adult, Age Factors, Aged, Female, Humans, Immune Tolerance, Male, Middle Aged, Neoplasms, Cohort Studies, HIV Infections, CD4 Lymphocyte Count, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.